Literature DB >> 6864677

Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.

W W Ginsburg, D L Conn, T W Bunch, F C McDuffie.   

Abstract

To evaluate the relationship between clinical manifestations and serologic markers in patients with systemic lupus erythematosus (SLE) and patients with an overlap syndrome, we reviewed the charts of 247 such patients who had been examined between 1975 and 1979. All patients with an overlap syndrome had a high frequency of arthritis and Raynaud's phenomenon and a low frequency of renal disease regardless of the presence or absence of antibody to nuclear ribonucleoprotein (anti-nRNP) and antibody to Sm antigen (anti-Sm). The presence or absence of anti-nRNP and anti-Sm did not distinguish whether a patient had SLE or an overlap syndrome and could not be used to predict clinical manifestations of disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864677

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis.

Authors:  P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 2.  Immunological features of diffuse connective tissue diseases.

Authors:  G R Burgio; A Martini
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

Review 3.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

4.  Diffuse systemic sclerosis and related diseases in Thailand.

Authors:  S Panicheewa; S Chitrabamrung; O Verasertniyom; M Vanichaphantu; S O Kraisit; P Chiewsilp; M Vatanasuk
Journal:  Clin Rheumatol       Date:  1991-06       Impact factor: 2.980

5.  Overlap connective tissue syndromes.

Authors:  R C Allen; C St-Cyr; P J Maddison; B M Ansell
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

6.  Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients.

Authors:  L S De Clerck; K A Meijers; A Cats
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 7.  Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature.

Authors:  J Braun; J Sieper; A Schwarz; F Hiepe; T Lenz; F Keller; H Herbst; A Distler
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 8.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.